Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Stake Purchase

Acacia circles over Woodford assets
Woodford has faced challenges in selling its shareholdings in spinouts including Oxford Nanopore and Immunocore, but has now lined up Acacia as a potential buyer.
Daily deal net: June 21, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
FutureLearn examines $65m investment
More than six years after being launched by Open University to offer massive open online courses, FutureLearn has raised its first external funding from Seek Group.
AskBio pops $235m question
Asklepios BioPharmaceutical, based on work by UNC Chapel Hill professors Jude Samulski and Xiao Xiao, has secured $235m in funding co-led by TPG Capital and Vida Ventures.
Meyer Burger manufactures Oxford PV stake
Meyer Burger picked up an 18% share in solar film manufacturing spinout Oxford PV, following a recent $41m first series D close for the spinout.
Sanofi hands $91m to Biontech
Biontech, a spinout of Johannes Gutenberg University Mainz, has received $91.5m in funding as part of the extension of a deal to develop a cancer immunotherapy candidate with Sanofi.
Argonaut enters JW Pharma’s orbit
Oxford spinout Argonaut Therapeutics has received $2.6m from JW Pharmaceuticals in return for a 25% stake.
Des Solutio finds its way out of Nova
Nova University Lisbon has established chemicals producer Des Solutio with the support of Frontier IP, making it the second spinout launched in Portugal by the commercialisation firm.

Other News

PGDx intersects with Innovatus in $42m deal
Johns Hopkins oncology diagnostics spinout PGDx had previously raised approximately $99m.
iThera optimises seven-digit round
Medical imaging company iThera spun out of Helmholtz Zentrum München in 2010 and has now been backed by lighting products maker Osram.
Allogene tallies up $120m
The cancer therapy developer has secured $120m in a convertible note offering featuring the University of California office of the chief investment officer.
Forendo fixes up $4.7m round
Vesalius has provided $4.7m to Forendo Pharma, whose existing shareholders also include Karolinska Development, Novartis, Novo and Merck Group.
Pfizer coughs up funding for Biontech
Biontech, an immunotherapy spinout of Johannes Gutenberg University Mainz, has received an undisclosed amount of equity funding as part of a collaboration deal that could reach $425m.

Editor's Picks

Big deal: QuantumScape fuels up on VW cash
VW will invest $100m in QuantumScape and form a joint venture with the Stanford spinout to develop batteries for long-range electric vehicles.
Revolymer sticks to AIM in IPO
Revolymer, which makes chewing gum that is easier to remove from streets and pavements, was backed by the Setsquared Partnership, a joint venture capital initiative between Bath, Bristol, Exeter, Southampton and Surrey.
test reg